While mutated or deleted RB cannot be replaced, preclinical studies utilizing CDK4/6 inhibitors have shown that these compounds have efficacy in retarding growth of certain bladder tumors in an RB dependent manner [22]. This evidence concerns the gene CDK4 and urinary bladder neoplasm.